Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Michael G. Heckman, Alexis Elbaz, Owen A. Ross, Matthew J. Farrer, Demetrius M. Maraganore, Georgia Xiromerisiou, Ruey Meei Wu, Zbigniew K. Wszołek, Karin Wirdefeldt, Linda R. White, Carles Vilariño‐Güell, Demetrios K. Vassilatis, Enza Maria Valente, Ryan J. Uitti, Hiroyuki Tomiyama, Vera Tadić, Leonidas Stefanis, Young H. Sohn, Peter A. Silburn, Manu Sharma, Aldo Quattrone, Simona Petrucci, Sung Sup Park, Grzegorz Opala, Eugénie Mutez, George D. Mellick, Timothy Lynch, Marie‐Anne Loriot, Katja Lohmann, Chin Hsien Lin, Elli Kyratzi, Rejko Krüger, Christine Klein, Yun Joong Kim, Beom S. Jeon, Barbara Jasinska Myga, John P A Ioannidis, Nobutaka Hattori, Georgios M. Hadjigeorgiou, Suzana Gispert, Brian Fiske, Alessandro Ferraris, Carlo Ferrarese, A. Destée, Efthimios Dardiotis, Marie‐Christine Chartier‐Harlin, Laura Brighina, Maria Bozi, Magdalena Boczarska Jedynak, Justin A. Bacon, Georg Auburger, Grazia Annesi, Jan Aasly, Daniel Serie, Alexandra I. Ortolaza (2014). Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.. , 35(1)
Article187 days agoAssociation of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
Owen A. Ross, Alexandra I. Soto‐Ortolaza, Michael G. Heckman, Jan Aasly, Nadine Abahuni, Grazia Annesi, Justin A. Bacon, Soraya Bardien, Maria Bozi, Alexis Brice, Laura Brighina, Christine Van Broeckhoven, Jonathan Carr, Marie‐Christine Chartier‐Harlin, Efthimios Dardiotis, Dennis W. Dickson, Nancy N. Diehl, Alexis Elbaz, Carlo Ferrarese, Alessandro Ferraris, Brian Fiske, J. Mark Gibson, Rachel A. Gibson, Georgios M. Hadjigeorgiou, Nobutaka Hattori, John P A Ioannidis, Barbara Jasińska‐Myga, Beom S. Jeon, Yun Joong Kim, Christine Klein, Rejko Krüger, Elli Kyratzi, Suzanne Lesage, Chin‐Hsien Lin, Timothy Lynch, Demetrius M. Maraganore, George D. Mellick, Eugénie Mutez, Christer Nilsson, Grzegorz Opala, Sung Sup Park, Andreas Puschmann, Aldo Quattrone, Manu Sharma, Peter A. Silburn, Young H. Sohn, Leonidas Stefanis, Vera Tadić, Jessie Theuns, Hiroyuki Tomiyama, Ryan J. Uitti, Enza Maria Valente, Simone van de Loo, Demetrios K. Vassilatis, Carles Vilariño‐Güell, Linda R. White, Karin Wirdefeldt, Zbigniew K. Wszołek, Ruey‐Meei Wu, Matthew J. Farrer (2011). Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study. , 10(10), DOI: https://doi.org/10.1016/s1474-4422(11)70175-2.
Article186 days agoLack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study
Alexis Elbaz, Lorene M. Nelson, Haydeh Payami, John P A Ioannidis, Brian Fiske, Grazia Annesi, Andrea Carmine Belin, Stewart A. Factor, Carlo Ferrarese, Georgios M. Hadjigeorgiou, Donald S. Higgins, Hideshi Kawakami, Rejko Krüger, Karen Marder, Richard Mayeux, George D. Mellick, John G. Nutt, Beate Ritz, Ali Samii, Caroline M. Tanner, Christine Van Broeckhoven, Stephen K. Van Den Eeden, Karin Wirdefeldt, Cyrus P. Zabetian, Marie Dehem, Jennifer S. Montimurro, Audrey Southwick, R Myers, Thomas A Trikalinos (2006). Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. , 5(11), DOI: https://doi.org/10.1016/s1474-4422(06)70579-8.
Article186 days agoUCHL1 is a Parkinson's disease susceptibility gene
Demetrius M. Maraganore, Timothy G. Lesnick, Alexis Elbaz, Marie‐Christine Chartier‐Harlin, Thomas Gasser, Rejko Krüger, Nobutaka Hattori, George D. Mellick, Aldo Quattrone, Jun‐ichi Satoh, Taksushi Toda, Jian Wang, John P A Ioannidis, Mariza de Andrade, Walter A. Rocca (2004). UCHL1 is a Parkinson's disease susceptibility gene. , 55(4), DOI: https://doi.org/10.1002/ana.20017.
Article186 days agoThe protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
Michael G. Heckman, Alexis Elbaz, Alexandra I. Soto‐Ortolaza, Daniel Serie, Jan Aasly, Grazia Annesi, Georg Auburger, Justin A. Bacon, Magdalena Boczarska‐Jedynak, Maria Bozi, Laura Brighina, Marie‐Christine Chartier‐Harlin, Efthimios Dardiotis, A. Destée, Carlo Ferrarese, Alessandro Ferraris, Brian Fiske, Suzana Gispert, Georgios M. Hadjigeorgiou, Nobutaka Hattori, John P A Ioannidis, Barbara Jasińska‐Myga, Beom S. Jeon, Yun Joong Kim, Christine Klein, Rejko Krüger, Elli Kyratzi, Chin‐Hsien Lin, Katja Lohmann, Marie‐Anne Loriot, Timothy Lynch, George D. Mellick, Eugénie Mutez, Grzegorz Opala, Sung Sup Park, Simona Petrucci, Aldo Quattrone, Manu Sharma, Peter A. Silburn, Young H. Sohn, Leonidas Stefanis, Vera Tadić, Hiroyuki Tomiyama, Ryan J. Uitti, Enza Maria Valente, Demetrios K. Vassilatis, Carles Vilariño‐Güell, Linda R. White, Karin Wirdefeldt, Zbigniew K. Wszołek, Ruey‐Meei Wu, Georgia Xiromerisiou, Demetrius M. Maraganore, Matthew J. Farrer, Owen A. Ross (2013). The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. , 35(1), DOI: https://doi.org/10.1016/j.neurobiolaging.2013.07.013.
Article186 days ago